cognitive cybersecurity intelligence

News and Analysis

Anesthesia and Respiratory Devices Market is expected to

Jersey City, New Jersey, Nov. 23, 2022 (GLOBE NEWSWIRE) — Verified Market Research recently published a report, “Anesthesia and Respiratory Devices Market” By Product (Anesthesia, Respiratory Devices), By End User (Hospitals, Ambulatory Service Centers, Homecare, Clinics), By Geographic…

Source: news.google.com – Read more

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

Zero-Day Attack Hits Cybersecurity Leader

The MITRE Corporation, a contributor to public interest cybersecurity, disclosed a data breach originating from a state-backed hack. Detected after suspicous activity was noticed on

Palo Alto Networks Discloses More Details on Critical PAN-OS Flaw Under Attack

Palo Alto Networks has revealed details of a critical security flaw- CVE-2024-3400 in its PAN-OS software being actively exploited by malicious actors. An intricate combination

A Better Connected Care Journey

The article urges healthcare organizations to move towards integrated, digitally enabled care delivery, replacing outdated point solutions. It acknowledges some may need help overcoming hurdles.

New patent expiration for Optinose Us drug XHANCE

Xhance, a drug marketed by Optinose US Inc, has fourteen patents. It has a total of 293 patent family members spanning across 29 countries. The

News and Analysis

Anesthesia and Respiratory Devices Market is expected to

Subscribe to newsletter

More Posts

Zero-Day Attack Hits Cybersecurity Leader

Palo Alto Networks Discloses More Details on Critical PAN-OS Flaw Under Attack

A Better Connected Care Journey

New patent expiration for Optinose Us drug XHANCE

Products

Solutions

Use Cases

News and Analysis

HEAL Security Insights

Company